Transcranial magnetic stimulation measures in the elderly: Reliability, smallest detectable change and the potential influence of lifestyle habits by Houde, Francis et al.
fnagi-10-00379 November 26, 2018 Time: 16:37 # 1
ORIGINAL RESEARCH
published: 27 November 2018
doi: 10.3389/fnagi.2018.00379
Edited by:
Ashok Kumar,
University of Florida, United States
Reviewed by:
Marco Iacoboni,
University of California, Los Angeles,
United States
Xiaoming Du,
University of Maryland, Baltimore,
United States
*Correspondence:
Louis-David Beaulieu
louis-David_Beaulieu@uqac.ca
Guillaume Leonard
guillaume.leonard2@usherbrooke.ca
Received: 11 May 2018
Accepted: 31 October 2018
Published: 27 November 2018
Citation:
Houde F, Laroche S, Thivierge V,
Martel M, Harvey M-P, Daigle F,
Olivares-Marchant A, Beaulieu L-D
and Leonard G (2018) Transcranial
Magnetic Stimulation Measures
in the Elderly: Reliability, Smallest
Detectable Change and the Potential
Influence of Lifestyle Habits.
Front. Aging Neurosci. 10:379.
doi: 10.3389/fnagi.2018.00379
Transcranial Magnetic Stimulation
Measures in the Elderly: Reliability,
Smallest Detectable Change and the
Potential Influence of Lifestyle Habits
Francis Houde1,2, Sarah Laroche1,2, Veronique Thivierge1,2, Marylie Martel1,2,
Marie-Philippe Harvey1,2, Frederique Daigle1,2, Ailin Olivares-Marchant1,
Louis-David Beaulieu2,3* and Guillaume Leonard1,2*
1 Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada, 2 Research Centre on Aging,
CIUSSS de l’Estrie – CHUS, Université de Sherbrooke, Sherbrooke, QC, Canada, 3 Biomechanical and Neurophysiological
Research Lab in Neuro-Musculo-Skelettal Rehabilitation, Université du Québec à Chicoutimi, Chicoutimi, QC, Canada
Background: Transcranial magnetic stimulation (TMS) is a non-invasive technique that
can be used to evaluate cortical function and corticospinal pathway in normal and
pathological aging. Yet, the metrologic properties of TMS-related measurements is still
limited in the aging population.
Objectives: The aim of this cross-sectional study was to document the reliability and
smallest detectable change of TMS measurements among community-dwelling seniors.
A secondary objective was to test if TMS measurements differ between elders based
on lifestyle, medical and socio-demographic factors.
Methods: Motor evoked potentials (MEPs) elicited by single-pulse TMS were recorded
in the first dorsal interosseous (FDI) in 26 elderly individuals (mean age = 70± 3.8 years).
Resting motor threshold (rMT), MEP amplitudes and contralateral silent period (cSP)
were measured on two separate occasions (1-week interval), and the standard error
of the measurement (SEMeas), intraclass correlation coefficient (ICC), and smallest
detectable change in an individual (SDCindv) were calculated. Lifestyle, medical and
socio-demographic factors were collected using questionnaires. TMS-related outcomes
were compared using independent sample t-test based on the presence of chronic
health diseases, chronic medication intake, obesity, history of smoking, physical activity
levels, gender, and level of education.
Results: rMT and cSP measures were the most reliable outcomes, with the lowest
SEMeas and highest ICCs, whereas MEP amplitude-related measures were less reliable.
SDCindv levels were generally high, even for rMT (7.29 %MSO) and cSP (43.16–
50.84 ms) measures. Although not systematically significant, results pointed toward a
higher corticospinal excitability in elderly individuals who were regularly active, who had
no chronic medical conditions and who did not take any medication.
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Conclusion: Even though SDCindv levels were relatively high, these results show that
rMT and cSP are the most reliable outcomes to investigate age-related changes in the
corticomotor system and suggest that the influence of factors such as lifestyle habits
and medications on TMS measures should be investigated further.
Keywords: transcranial magnetic stimulation, aging, elderly, lifestyle habits, chronic disease, reliability, smallest
detectable change
INTRODUCTION
Normal aging is characterized by a decline in cognitive and
sensorimotor functions, paralleled by progressive changes in the
CNS structure, function, and biochemistry (for reviews cf. Seidler
et al., 2010; Turner and Spreng, 2012; Rossini et al., 2015).
The neurophysiological mechanisms underpinning age-related
decline in motor performance can be probed by TMS (reviewed
in Levin et al., 2014). TMS is a safe and non-invasive method to
assess the excitability and integrity of the motor cortex and the
corticospinal tract, as well as intracortical and interhemispheric
inhibitory/excitatory mechanisms involved in motor control
(Kobayashi and Pascual-Leone, 2003; Reis et al., 2008; Rossi
et al., 2009; Rossini et al., 2015). Since its introduction by Barker
et al. (1985), TMS has been increasingly used worldwide, and
its basic principles and guideline procedures are described in
reference publications (e.g., Groppa et al., 2012; Rossini et al.,
2015). In short, a time-varying magnetic field is induced by
an electrical current passing through a magnetic coil. When
the coil is placed over the primary motor cortex (M1) on the
subject’s scalp, the magnetic pulse trans-synaptically depolarizes
pyramidal neurons in M1 via cortical horizontal connections.
With sufficient stimulus intensity, descending volleys are elicited
in the corticospinal tract and a MEP is recorded in contralateral
muscles with surface EMG electrodes. Several outcomes can be
derived from MEP recordings based on various single and paired-
pulse paradigms, with the targeted muscle at rest or slightly
contracted (Groppa et al., 2012; Rossini et al., 2015).
Previous TMS studies which have compared young and
older adults provided evidence of altered M1 excitability
and inhibitory/excitatory mechanisms with age, which were
sometimes directly correlated to sensorimotor deficits (Levin
et al., 2014). For example, two studies from Fujiyama’s group
(Fujiyama et al., 2009, 2012) revealed that younger adults
exhibited longer cSP [i.e., a transient suppression of the ongoing
EMG activity caused inhibitory mechanisms (Paulus et al.,
2008; Rossini et al., 2015)] compared to older participants.
Interestingly, cSP length was linked to motor performance in
the older group executing more difficult inter-limb coordination
tasks; those having the lowest performance showed the shortest
cSP durations (Fujiyama et al., 2012). Other research groups
reported lower M1 and corticospinal excitability in old vs. young
Abbreviations: BMI, body mass index; CNS, central nervous system; cSP,
contralateral silent period; CVs, coefficients of variation; EMG, electromyography;
FDI, first dorsal interosseous; ICC, intraclass correlation coefficient; MEPs, motor
evoked potentials; MVC, maximum voluntary contraction; M1, primary motor
cortex; RC, recruitment curve; rMT, resting motor threshold; MSO, stimulator’s
maximum output; SEMeas, standard error of the measurement; SDCindv, smallest
detectable change for an individual; TMS, transcranial magnetic stimulation.
adults (Rossini et al., 1992; Pitcher et al., 2003; Oliviero et al.,
2006), as revealed by higher motor thresholds (i.e., the lowest
TMS intensity required to elicit a MEP), lower MEP amplitudes
and altered properties of the input–output recruitment curves
(RC, representing the relation between a wide range of TMS
intensities and the resulting MEP amplitudes – for more details
cf. Groppa et al., 2012; Rossini et al., 2015).
However, the psychometric evaluation of TMS-related
measurements (i.e., validity, reliability, responsiveness, cf.
Portney and Watkins, 2009) is still limited (Schambra et al.,
2015). Evidence pointed out so far that most TMS outcome
measures present with a certain degree of variability caused by
various biological and methodological factors (Kiers et al., 1993;
Schulz and Ferbert, 1996; van der Kamp et al., 1996; Maeda
et al., 2002; Wassermann, 2002; Orth et al., 2003; Orth and
Rothwell, 2004; Darling et al., 2006; Rosler et al., 2008; Jung et al.,
2010; Roberts et al., 2011). Such variability put into question the
reliability of TMS measures, i.e., their accuracy and consistency
in stable individuals (Portney and Watkins, 2009). To date,
the reliability of TMS measures has been mostly studied in
healthy adults (cf. systematic review by Beaulieu et al., 2017) and
stroke populations (Koski et al., 2007; Liu and Au-Yeung, 2014;
Schambra et al., 2015), but results are still scarce and extremely
variable across studies and only a few studies investigated the
geriatric population (Wolf et al., 2004; Christie et al., 2007;
Schambra et al., 2015). This is problematic since previous studies
that focused on the impact of age on TMS measurements showed
that TMS outcomes differ between younger and older adults
(Pitcher et al., 2003; Smith et al., 2011), hence limiting the
generalization of most TMS-reliability evidence to the elderly.
More research investigating the reliability of TMS measures
in the elderly population could thus improve our collective
understanding and appropriate use of this neurophysiological
tool for studying how motor control is affected in the aging brain.
Interestingly, a recent literature review pointed out that
results are sometimes controversial between papers that
investigated age-related changes with TMS (Levin et al.,
2014). Based on the heterogeneity that characterizes the
elderly population, it can be hypothesized that factors such as
lifestyle habits and socio-demographic characteristics could
in part explain the variable results in the TMS literature.
Cumulative neuroimaging evidence already support that these
factors might have a strong impact on the CNS (Mahncke
et al., 2006; Vaynman and Gomez-Pinilla, 2006; Seidler
et al., 2010; Debette et al., 2011; Habes et al., 2016), but an
investigation tackling how such factors can influence age-
related changes in the brain has never been attempted with
TMS.
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The primary aim of this cross-sectional study was to
characterize the absolute reliability (a.k.a. measurement error),
relative reliability and smallest detectable change levels for
an individual of TMS-related measures within the elderly
population. Based on the results obtained in the literature
(Badawy et al., 2011; McGregor et al., 2012; Liu and Au-
Yeung, 2014; Schambra et al., 2015; Beaulieu et al., 2017), we
hypothesized that the rMT and the cSP would be the most
reliable outcome, conversely to all MEP amplitude-related
outcomes. As a secondary objective, we performed exploratory
analysis to compare TMS-related outcomes based on the
presence of chronic health diseases, chronic medication intake,
obesity, history of smoking, physical activity levels, gender,
and level of education among functionally independent and
community-dwelling seniors without any known cognitive or
neurological disorders. Based on the literature, we hypothesized
that participants having poorer health and lifestyle habits
(sedentarity, history of smoking, obesity, chronic medication
intake, and chronic diseases) would exhibit shorter cSP durations
and lower M1 and corticospinal excitability (characterized by
higher motor thresholds, lower MEP amplitudes and lower
slopes of input–output RC).
MATERIALS AND METHODS
Participants
Twenty-six elderly individuals were recruited in the general
population of the Sherbrooke area after providing informed
written consent approved by the local ethics committee. The
participants’ characteristics are detailed in Table 1. The inclusion
criteria were: age ≥ 65 years old; functionally independent
in their activities of daily living; good vision. The general
exclusion criteria were: any cognitive, psychiatric, or neurological
disorders; any upper limb orthopedic injury or disease. Specific
exclusion criteria related to TMS further included a history of
seizures, cardiac pacemaker and intracranial metallic implants
(Rossi et al., 2009). Participants were instructed not to change
their medication intake and other lifestyle habits during the
study.
Experimental Procedure
The study took place at the Research Centre on Aging
(Sherbrooke, QC, Canada) and consisted in two visits separated
by a 1-week interval. TMS procedures were strictly replicated
between the two testing sessions by the same investigator
per participant. All relevant participant-related information,
consisting of lifestyle habits (frequency of physical activity,
smoking), medical (chronic diseases and chronic medication
intake) and socio-demographic (age, height, weight, race, highest
completed level of education) factors were collected using a
questionnaire.
Electromyography (EMG)
After standard skin preparation (Hermens et al., 2000), two
Ag/AgCl surface recording electrodes (1 cm2 recording area)
were positioned following a belly-tendon montage on the
TABLE 1 | Characteristics of participants.
General and
socio-demographic
characteristics
Participants (N) 26
Age (mean ± SD) 70.0 ± 3.8 years
Gender (N: males/females) 13/13
Handedness (N: right/left) 26/0
Race
- Caucasian/other 26/0
Highest education level (N)
- Secondary 11
- Post-secondary 15
Anthropometry
(mean ± SD)
- Height 1.64 ± 0.11 m
- Weight 72.4 ± 13.8 kg
- BMI 26.7 ± 2.9 kg/m2
- Overweight∗ (N: yes/no) 19/7
Lifestyle habits
Physical activity∗∗ (N:
regular/sedentary)
19/7
Smoking (N: yes/no)
- Currently smoking 0/26
- History of smoking 13/13
Medical characteristics
Chronic disease (N:
yes/no) - Diagnostic (N)
15/11-Arthritis (3); Benign prostatic hyperplasia (2);
Crohn disease (1); Diabetes (2);
Hypercholesterolemia (5); Hypertension (10);
Hypothyroidism (3); Intercostal neuralgia (1);
Osteoarthritis (4); Sleep apnea (1); Tinnitus (1)
Chronic medication intake
(N: yes/no)
17/9
- Main effect (Drug)∗∗∗ Anticholesteremic (Atorvastatin, Rosuvastatin,
Simvastatin); Anticoagulant (Rivaroxaban);
Antidepressant/anxiolytic (Escitalopram,
Hydroxyzine, Trazodone, Venlafaxine);
Antidiabetic (Glyburide, Metformin, Pioglitazone,
Saxagliptin, Sitagliptin); Antihypertensive
(Amlodipine, Amiloride, Cilazapril, Diltiazem,
Hydrochlorothiazide, Irbesartan, Lisinopril,
Losartan, Metoprolol, Quinapril, Telmisartan,
Valsartan); Anti-inflammatory (Acetaminophen,
Acetylsalicylic acid, Celecoxib,
Hydroxychloroquine); Antiosteoporotic
(Alendronate); BPH-medication (Alfuzosin,
Dutasteride, Tamsulosin);
Chemotherapy agent/immune system suppressant
(Methotrexate); Gastric acid inhibitor
(Esomeprazole, Omeprazole, Pantoprazole);
Hormone replacement therapy (Estrone,
Levothyroxine, Premarin); Laxative (Docusate);
Topical corticosteriod (Clobetasol);
Uric acid synthesis inhibitor (Allopurinol)
∗Overweight is defined as BMI ≥ 25. ∗∗Regular physical activity was defined as ≥ 1
session per week. ∗∗∗Drugs in bold are those passing through the blood brain
barrier (source: www.drugbank.ca). BMI, body mass index (weight/height2); N,
number of participants.
FDI muscle of the dominant hand. More specifically, one
electrode was placed over the belly muscle and the other was
fixed on the lateral side of the second metacarpo-phalangeal
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joint. A third ground electrode was secured over the radial
styloid process. The EMG signals were amplified and filtered
(200 Hz – 2 kHz) with a CED 1902 amplifier (Cambridge
Electronic Design Limited, Cambridge, United Kingdom) and
digitized at a sampling rate of 10 kHz with a Power 1401
mk II interface and Spike 2 software (version 7.10; Cambridge
Electronic Design Limited, Cambridge, United Kingdom). All
TMS outcomes required complete muscle relaxation (except for
cSP), EMG signals prior to each TMS impulse were visually
monitored online and inspected during post hoc analyses. Any
trial in which pre-impulse electrical activity was detected was
discarded.
Transcranial Magnetic Stimulation (TMS)
Procedures
Participants were comfortably seated on a standard chair
throughout TMS testing procedures, which respected published
guidelines in the field (cf. Groppa et al., 2012; Rossini et al.,
2015). Magnetic stimuli (monophasic waveform) were delivered
using a 70 mm figure eight coil connected to a Magstim
200 TMS device (Magstim Company, Ltd., United Kingdom).
The coil handle was held approximately perpendicular to
the skull and oriented at 45◦ in the mid-sagittal plane to
induce a posterior-to-anterior electrical current direction in the
cortex. The optimal site for eliciting MEPs in the contralateral
FDI with the lowest stimulation intensity (hotspot) was first
determined by moving the coil 1 cm at a time over the
hand’s M1 area [located approximately 1 cm anterior and
4 cm lateral to the vertex based on the 10–20 EEG system
(Klem et al., 1999)] while stimulating at 40% of the stimulator’s
maximum output (MSO). The TMS intensity was increased
above 40% MSO if no MEP was elicited. Once located, the
coil’s position above the hotspot was traced on a bathing cap
worn by the subject, and the experimenter regularly verified
that the coil was correctly positioned throughout the session.
These procedures were precisely replicated on the second
visit.
Resting Motor Threshold (rMT)
The rMT was defined as the lowest TMS intensity (in %MSO)
required to induce MEPs amplitude of over 50 µV in four out
of seven trials in the resting FDI. To this end, TMS intensity was
slowly decreased by 2% steps until MEPs≥ 50µV were no longer
elicited. The intensity was then increased by 1% steps until the
rMT criterion was met.
Recruitment Curve (RC)
At rest, five blocks of different stimulation intensity (i.e., 90, 110,
120, 130, and 150% of the rMT) were randomly provided to
participants, each block consisting in 10 magnetic stimuli. Time
between each magnetic stimulus was randomly varied between 5
and 10 s, by the computer. MEPs that were below 50 µV were
excluded from the analysis (except at 90% of rMT). Recruitment
curves were constructed by expressing the mean peak-to-peak
MEP amplitudes (y-axis) based on the corresponding stimulus
intensity in % rMT (x-axis).
Contralateral Silent Period (cSP)
Contralateral silent periods were obtained from two stimulation
blocks at 120 and 130% of the rMT (in %MSO), each block
consisting of 10 TMS stimuli separated by 5–10 s (randomly
determined by the computer). TMS stimulations were delivered
while the subjects sustained a slight isometric activation with
their FDI (thumb-index pinch) at 10% of MVC, determined by
the average of three trials in which participants were asked to
apply their maximum pressure on a pinch gauge (North Coast
Medical, Inc., Morgan Hill, CA, United States). During the trials,
participants were asked to maintain 10% of their MVC, which was
monitored visually by the evaluator on the pinch gauge.
Data Pre-processing and Statistical
Analysis
Motor evoked potential amplitudes and cSP durations were
measured oﬄine with the Spike 2 software. Precisely, a script
automatically marked the exact time at which the TMS
stimulation was triggered and then calculated the MEP peak-
to-peak amplitude within a 100 ms window starting 10 ms
post-stimulation. The cSP onset (start of the cSP) was defined
as the time where the EMG signal returned to the baseline (i.e.,
no EMG activity) after the MEP and the cSP offset (end of the
cSP) was defined as the return of the voluntary contraction.
These points were determined visually from the raw EMG
recordings. Concerning RC outcomes, the expression of MEP
amplitude in function of TMS intensity habitually results in an
“s-shaped” curve that can be best fitted using the Boltzmann
sigmoidal function (Devanne et al., 1997), providing several
measures having interpretable neurophysiological underpinnings
(e.g., MEP amplitude plateau, slope of the Boltzmann curve, etc.,
cf. Devanne et al., 1997). However, in the present study, RC data
with the older population rather resulted in a relatively linear
increase of MEPs amplitude [a situation which was observed
by other researchers – see for instance (Chen et al., 1998)].
Precisely, a sigmoidal fit was only realizable in six out of the
26 participants. Hence, the Boltzmann equation was impossible
to compute, and mean slopes were obtained by using linear
regression analyses.
Statistical analyses were performed using the Statistical
Package for the Social Sciences (SPSS) software (version 17).
Statistical assumptions for parametric tests and reliability
analyses were explored by determining the data’s normality
and homoscedasticity (Atkinson and Nevill, 1998; Weir,
2005; Portney and Watkins, 2009). Normality was assessed
by visual screening of histogram distributions and by the
Shapiro–Wilk test allowing us to assume that the data were
normally distributed (Henderson, 2006; Ghasemi and Zahediasl,
2012). Homoscedasticity [i.e., the absence of heteroscedasticity
(Weir, 2005)] was tested following the procedure detailed in
Damron et al. (2008), that is by exploring the correlation
between the size of the measurement error and the magnitude
of the observed scores. For example, in the presence of
heteroscedasticity, individuals with higher scores would show
a higher random error measure than those with lower
scores. As recommended, whenever non-normal distributions
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or heteroscedasticity were found, a logarithmic (natural)
transformation of the outcome was applied (Atkinson and
Nevill, 1998; Schambra et al., 2015; Beaulieu et al., 2017),
and further analyses were performed on the log-transformed
data.
For the study’s primary objective, the measurement error
of TMS-related outcomes was evaluated using the standard
error of the measurement (SEMeas) (Weir, 2005). SEMeas is
expressed in the same unit as the measure; the smaller its
value, the more reliable the measure is Weir (2005). The
following formula was used: SEMeas =
√
MSE where MSE is
the mean squared error term (or “residual error”) obtained
from the ANOVA applied on test and retest measurements
(Weir, 2005). Each SEMeas was normalized to the pooled mean
from both testing sessions (named SEMeas%), using the formula
SEMeas% = SEMeas/pooled mean∗100. This method enabled the
comparison of the measurement error between TMS outcomes
by expressing them on the same scale (%) (Lexell and Downham,
2005; Schambra et al., 2015). We used the cut-off of <10%
as an arbitrary value for suggesting low measurement error
(Schambra et al., 2015). The smallest detectable change for
an individual or SDCindv (a.k.a. minimal detectable change or
smallest real difference) was calculated from SEMeas scores, as
follows: SDCindv = SEMeas∗1.96∗
√
2 (Beckerman et al., 2001).
Relative reliability (a.k.a. reliabilityMP, cf. Mokkink et al., 2010)
was tested by the ICC (Weir, 2005). Our study considered ICC
scores to be good from 0.75 to 0.89 and excellent if ≥ 0.90,
although no absolute benchmarks exist for the interpretation
of ICC scores (Weir, 2005; Portney and Watkins, 2009). ICCs
of TMS measures were calculated using the two-way random
effects “absolute agreement” model in SPSS (a.k.a. model 2,k –
cf. Weir, 2005). The presence of systematic differences in TMS
measures between sessions 1 and 2 was explored using paired
sample t-tests.
For the secondary objective, subgroups depending on
behavioral, medical, and socio-demographic factors were created,
based on the following dichotomous classifications: male/female;
presence/absence of a diagnosed chronic disease, independently
of the type of disease; presence/absence of chronic medication
intake; highest level of education secondary (a.k.a high
school/post-secondary); regular physical activity≥ 1/< 1 session
per week; history of smoking/never smoked. Independent sample
t-tests were used to compare all TMS outcomes between the
subgroups. Statistical significance was set at p < 0.05 for all
analyses.
RESULTS
Participants’ Characteristics
The general, socio-demographic, lifestyle habits and medical
characteristics of the 26 participants are detailed in Table 1. All
were right-handed (mean age = 70.0 ± 3.8 years). Most second
objective subgroups were balanced, particularly gender (13 males
and 13 females), history of smoking (13 smoked in the past
and 13 did not), highest level of education (15 post-secondary
and 11 secondary) and chronic disease (15 having one or more
chronic disease and 11 having none). The other subgroups
consisted in chronic medication intake (17 taking one or more
medication on a regular basis and 9 taking none), BMI (19 being
considered overweight and 7 were not) and physical activity (19
were regularly active and 7 were not). Most chronic illnesses
consisted in arthritis/osteoarthritis and vascular risk factors
(diabetes, hypertension, hypercholesterolemia), conditions which
are highly prevalent in the elderly population (Espeland et al.,
2017). Furthermore, 13 participants took at least one drug
known to pass through the blood brain barrier (these drugs
are in bold in the Table 1), and five subjects were prescribed
antidepressant/anxiolytic medications, potentially influencing
brain activity via the inhibition of serotonin/norepinephrine
reuptake mechanisms (Paulus et al., 2008; Ziemann et al., 2015).
Of note, the subgroups “chronic disease” and “medication intake”
were comprised of the same individuals, except for two women
who were taking estrogen replacement therapy, as menopausal
symptoms were not considered as a chronic disease.
Missing TMS Data
Two participants included in this study had exceptionally high
rMT (%MSO) values, which made it impossible to record MEP
values at 150% rMT (n = 2) and 130% rMT (n = 1) since it
exceeded the capacity of the stimulator (i.e., over 100% MSO).
Less than 5% of all the MEPs obtained at suprathreshold intensity
were below the 50 uV threshold and were excluded from the
analysis.
Raw TMS Outcomes
Raw (i.e., untransformed) TMS measures are presented in Table 2
for the entire group. Between-session comparisons revealed no
systematic difference in TMS outcome measures, except for rMT
which showed a slight increase of 1.8 ± 3.7 %MSO (p = 0.02)
between sessions 1 and 2. MEP amplitudes and RC mean slope
data showed non-normal distributions or heteroscedasticity.
Following natural log transformation, MEP amplitudes and RC
mean slope data was normally distributed and the assumption
of homoscedasticity was respected. All further analyses for MEP
amplitudes and RC mean slope were therefore realized on log-
transformed data.
Reliability
Results for measurement error, smallest detectable change for an
individual (SDCindv) and reliabilityMP are presented in Table 3,
along with the pooled means and CVs calculated from the two
sessions that are critical for having a correct interpretation and
generalization of ICC results (Schambra et al., 2015; Beaulieu
et al., 2017). Indeed, high data dispersion (i.e., high CVs)
increases the chance of obtaining high ICC scores (Weir, 2005;
Schambra et al., 2015). Of note, reliability results for MEP
amplitudes and RC mean slope are given in both log transformed
and raw data (light gray in Table 3). Although log transformed
results are more valid because they were corrected for non-
normal or heteroscedastic distributions), we have decided to also
present the reliability of untransformed measures to ease the
interpretation of the results.
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TABLE 2 | Raw TMS measures.
Session 1 Session 2
Mean ± SD (CV) Mean ± SD (CV)
rMT (%MSO) 49 ± 12 (24.5) 51 ± 12 (23.5)∗
MEP amplitude (µV)
- 90% rMT 21.58 ± 11.66 (54.0) 23.57 ± 16.10 (68.3)
- 110% rMT 216.01 ± 194.04 (89.8) 232.08 ± 173.53 (74.8)
- 120% rMT 269.33 ± 171.01 (63.5) 318.52 ± 206.01 (64.7)
- 130% rMT 372.00 ± 196.10 (52.7) 434.32 ± 337.07 (77.6)
- 150% rMT 477.97 ± 266.38 (55.7) 552.94 ± 444.05 (80.3)
RC mean slope (µV/% rMT) 7.52 ± 4.31 (57.3) 8.50 ± 7.65 (90.0)
cSP duration (ms)
- 120% rMT 92.89 ± 36.77 (39.6) 95.09 ± 31.13 (32.7)
- 130% rMT 97.37 ± 44.86 (46.1) 99.74 ± 43.19 (43.3)
∗Significant difference (p < 0.05) between sessions. Underlined TMS outcomes
were those that required a natural log transformation because of non-normal
distributions or heteroscedasticity. cSP, contralateral silent period; CV, coefficient of
variation [100∗(SD/mean)]; MEP, motor evoked potentials; MSO, maximal stimulator
output; RC, recruitment curve; rMT, resting motor threshold.
Measurement errors were low for rMT (%SEMeas: 5.30%),
high for all MEP amplitudes and RC mean slope (51.91–70.97%)
and moderate for cSP measures (16.56–17.70%). ICCs provided
evidence of excellent reliability for rMT and cSP, which were
particularly high for the former with an ICC and 95% confidence
intervals above 0.90 (see Table 3), even though pooled CVs were
not particularly high (23.78–38.36%). Inversely, all remaining
outcomes (MEP amplitude and RC mean slope) showed low
ICCs with very large confidence intervals, despite important data
dispersion (all pooled CVs above 60%; see Table 3).
SDCindv were relatively high for all TMS measures. For
instance, in order to conclude with 95% confidence that a change
occurred when measuring the rMT with the elderly population,
an increase/decrease would need to reach more than 7.29 %MSO
(see Table 3 for SDCindv levels of all TMS outcomes).
Comparisons Between Subgroups
General and Socio-Demographic Characteristics
Compared to men, women were significantly lighter (p < 0.001)
and smaller (p < 0.001), but the BMI (in kg/m2) was not
different (p = 0.37). No difference in TMS measures was found
between subgroups, based on socio-demographic characteristics
(i.e., gender, education level, and BMI; all p-values > 0.17).
Lifestyle Habits
As shown in Figure 1A, physically active individuals (i.e., ≥1
session of physical activity per week) had lower rMT at session
2 (p = 0.05), but not at session 1 (p = 0.13). The difference
between subgroups were 7.7 %MSO ( ± 4.95) at session 1 and
10.4 %MSO (± 5.11) at session 2. No other significant difference
based on behavioral characteristics was found for the remaining
TMS outcomes (all p-values > 0.1).
Medical Characteristics
Figures 1 and 2 illustrate the differences observed between
subgroups based on their medical characteristics. First,
individuals having chronic medical conditions showed higher
rMT values at session 1 (p = 0.04, mean difference: 9.4 ± 4.25
%MSO) which was nearly significant at session 2 (p = 0.06, mean
difference: 9.2 ± 4.59 %MSO; see Figure 1B). These effects were
not found for the subgroup taking medication on a regular basis
TABLE 3 | Reliability results (n = 26).
Measurement error Reliability Pooled data
TMS outcomes (units) SEMeas %SEMeas SDCindv ICC Lower 95%CI Upper 95%CI Mean CV
rMT (%MSO) 2.63 5.30 7.29 0.970 0.922 0.987 49.67 23.76
LogN_MEP amplitude (NA)
- 110% rMT 0.51 NA 1.42 0.468 0 0.763 NA NA
- 120% rMT 0.45 NA 1.24 0.542 0 0.794 NA NA
- 130% rMT 0.51 NA 1.42 0.511 0 0.787 NA NA
- 150% rMT 0.53 NA 1.46 0.472 0 0.774 NA NA
Raw MEP amplitude (µV)
- 110% rMT 158.99 70.97 440.70 0.413 0 0.740 224.04 81.43
- 120% rMT 152.60 51.91 422.98 0.516 0 0.781 293.92 64.35
- 130% rMT 234.61 58.19 650.32 0.434 0 0.750 403.16 68.14
- 150% rMT 335.90 65.17 931.06 0.277 0 0.689 515.45 70.66
LogN_RC mean slope (NA) 0.55 NA 1.53 0.517 0 0.785 NA NA
Raw RC mean slope (µV/%rMT) 5.53 69.11 15.34 0.346 0 0.709 8.01 77.00
cSP duration (ms)
- 120% rMT 15.57 16.56 43.16 0.886 0.747 0.949 93.99 35.91
- 130% rMT 18.34 17.87 50.84 0.885 0.733 0.950 102.66 38.36
Results in light gray color are those obtained from untransformed measured (even though they showed non-normal or heteroscedastic distributions). 95%CI: 95%
confidence intervals; cSP, contralateral silent period; CV, coefficient of variation; ICC, intraclass correlation coefficient; LogN, data transformed using a natural logarithm;
MEPs, motor evoke potentials; MSO, maximal stimulator output; NA, not applicable (for log transformed outcomes); RC, recruitment curve; rMT, resting motor threshold;
SDC, smallest detectable change; SEMeas, standard error of the measurement.
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FIGURE 1 | (A) Physically active individuals had lower rMT at session 2 but
not at session 1. (B) Individuals having chronic medical conditions showed
higher rMT values at session 1, and a significant trend (p = 0.06) was
observed at session 2. (C) Participants taking medication showed longer cSP
at 120% rMT at session 1; no differences in cSP were noted at session 2.
∗Significantly different (p < 0.05) between sessions; trend (p < 0.10).
(p-values> 0.1; mean difference observed at session 1 = 6.4± 4.7
%MSO; mean difference observed at session 2 = 6.3 ± 5.0%).
cSP at 120% rMT were longer in the medicated subgroup
at session 1 (p = 0.03; mean difference: 32.7 ± 13.95 ms),
suggesting increased intracortical inhibition in individuals who
took medication. However, no differences in cSP were noted
at session 2 (p = 0.17, mean difference 17.88 ± 12.58 ms; see
Figure 1C). Of note, those suffering from chronic illnesses
and taking medications on a regular basis were older and had
a higher BMI than “healthy” subgroups (see Figures 2A,B).
Precisely, compared to their counterparts, the “chronic disease”
and “medication intake” subgroups respectively showed mean
differences of 3.4 ± 1.4 years (p = 0.01) and 3.6 ± 1.3 years
(p = 0.03), 3.0 ± 1.0 kg/m2 (p = 0.01) and 3.15 ± 1.03 kg/m2
(p = 0.01). To further explore the potential influence of age and
BMI level on rMT and cSP results, Pearson’s correlation analyses
were conducted for the whole group, and for each subgroup
(disease and medication) at each session. The analyses revealed
no relationship between rMT/cSP and age and between rMT/cSP
and BMI (all p-values > 0.1).
FIGURE 2 | Participants having chronic diseases and who took medication
were older (A) and had higher body mass index (B). ∗p < 0.05; ∗∗p < 0.01.
DISCUSSION
Main Findings
The present study assessed the measurement error, smallest
detectable changes, and relative reliability of TMS-related
measurements among functionally independent and community-
dwelling seniors. Along with our previous hypothesis, the rMT
and cSP were the most reliable TMS-outcomes in the elderly
while the MEP amplitude-related outcomes (MEP amplitude and
RC) had lower reliability.
This study also compared TMS outcome measures in
community-dwelling elders based on socio-demographic,
lifestyle habits and medical factors. To our knowledge, this
is the first study investigating these questions, as previous
work in the field tended to focus on the “age” factor only.
Although a few limitations might affect the strength of our
findings, results mostly supported our initial hypotheses, as
corticospinal excitability was lower in elders with poorer lifestyle
habits/general health when compared to those presenting with
healthier behaviors/fewer medical problems.
Reliability and Smallest Detectable
Change of TMS Measures in the Elderly
Our reliability results showed a lower percentage of error and
higher ICCs for the rMT and cSP compared to the other
TMS measures, which is in line with the literature (Badawy
et al., 2011; McGregor et al., 2012; Liu and Au-Yeung, 2014;
Schambra et al., 2015; Beaulieu et al., 2017). These results further
support the use of these TMS measures for both evaluative
and diagnostic/prognostic purposes with the geriatric population
(Weir, 2005; Schambra et al., 2015; Beaulieu et al., 2017). Future
studies with similar population characteristics will be able to
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use the reliability metrics provided in Table 3, for example to
anticipate how much an individual (SDCindv) or group [SDCindv
divided by the square root of their sample size (see Terwee
et al., 2007; Schambra et al., 2015)] would have to change to
be above the measurement’s error. This provides an analytic
method that is complementary to standard hypothesis testing
(Schambra et al., 2015). For example, although differences in
rMT between subgroups based on lifestyle habits were not always
statistically significant in this study, they were above the group
SDC levels.
Conversely to the rMT and cSP, MEP amplitudes and
RC mean slope presented with relatively high SEMeas and
SDCindv levels, and with low ICC scores. Many previous reports
also obtained poor reliability metrics in younger populations,
particularly for MEP amplitudes (Livingston and Ingersoll,
2008; Fleming et al., 2012; Ngomo et al., 2012; Beaulieu
et al., 2017). Our results might be due in part to our
inability to fit the Boltzmann function (Devanne et al., 1997)
in most participants; future studies are thus encouraged to
collect supplemental TMS intensities to construct a reliable
RC sigmoidal curve with the older population, particularly
at higher TMS intensities to ensure that a MEP plateau is
reached. Clearly, the very high measurement errors and low
ICCs (observed even after having performed a log natural
transformation), call for a change of practice in MEP amplitude
acquisition. Recent studies looked into the effect of the number
of delivered stimuli (cf. reviews by Beaulieu et al., 2017;
Cavaleri et al., 2017), or the use of electroencephalography
to control the timing of TMS pulse delivery, depending on
the ongoing state of the brain’s oscillatory activity (Ferreri
et al., 2014; Keil et al., 2014; Zrenner et al., 2018). In one
of these studies, Chang et al. (2016) used Cronbach alpha to
document the internal consistency of TMS measures obtained
with paired-pulse paradigms. They showed that about 20–25
trials are required to reach an appropriate level of trial-to-
trial consistency for paired-pulse outcomes. Although their
work brings important knowledge to the field of TMS, internal
consistency should not be interpreted the same way as SEMeas,
ICC and SDC, as it mostly considers only one source of
variability (i.e., intrinsic physiological variability) if the setup and
evaluator are kept the same. Other studies tried to determine
if the number of stimuli could influence reliability scores
(so far, only with the ICC), but results are inconsistent (see
the recent review on the topic by Cavaleri et al., 2017). It
should also be remembered that ICC is probably not the best
indicator, as it does not describe measurement variability/error
(Weir, 2005; Schambra et al., 2015; Beaulieu et al., 2017).
Recording 20–25 stimuli for TMS measures of intracortical
inhibition and facilitation is probably ideal (Ngomo et al., 2012;
Beaulieu et al., 2017). However, this practice might not be
reasonable to produce RC curves (i.e., 20–25 trials for each
TMS intensity), especially in older populations, as this lengthens
the procedures and could introduce physical and cognitive
fatigue.
Comparing our data with the available evidence in literature
is difficult, based on the very high heterogeneity across
published studies on TMS reliability (Beaulieu et al., 2017),
and because reliability indices such as ICC are not easily
generalizable as it depends on the sample dispersion in a
way that higher inter-subject variation tends to increase ICC
values, and vice-versa (Weir, 2005). Interestingly, the lower
reliability scores for RC measures in our study – as compared
to papers having tested younger adults (Beaulieu et al., 2017) –
encourage future work to compare the reliability between
younger and older adults. Having higher/lower variability
of TMS measures in elders could lead to further research
on the neurophysiological underpinnings of such differences.
For instance, it could be hypothesized that brain atrophy
with age has a general dampening effect on TMS variables
(Rossini et al., 1992; Pitcher et al., 2003; Oliviero et al.,
2006; Levin et al., 2014), hence reducing inter-subject variation
(potentially resulting in lower ICCs) and limiting the ability
of physiological processes tested by TMS to vary (potentially
resulting in less measurement error). Alternately, an increase
in the intra-individual variability of cognitive and perceptivo-
motor functions has been observed and proposed as a biomarker
of aging (MacDonald et al., 2006), hence potentially increasing
the within-subject measurement error and resulting in both
lower relative (ICC) and absolute reliability (SEMeas). Knowing
that the intrinsic variability of TMS measures could be in part
linked to normal fluctuations of physiological processes (Rossini
et al., 2015), it is expected that older persons will exhibit higher
trial-to-trial variation, thus affecting both relative and absolute
reliability. These important questions should be tackled in future
work.
Comparisons Based on
Socio-Demographic, Lifestyle Habits,
and Medical Factors
Resting motor thresholds tended to be higher in the presence
of chronic diseases, medication intake and sedentary behaviors.
Although the results were not particularly strong and not
systematically significant in visit 1 and visit 2, these observations
point toward a higher excitability of M1 and the corticospinal
tract (lower rMT values) in “healthier” subgroups, thus
suggesting that these behavioral and medical factors might
influence age-related changes within the motor cortex.
Evidence from other neurophysiological tools than TMS
already highlighted the impact of lifestyle habits and medical
affections on the CNS. For instance, a recent large-scale study
using magnetic brain imaging with 592 community-dwelling
elders observed a significant and positive correlation between
the level of brain atrophy and the annual medical expenditure
which represents a financial way to evaluate the health status
of a person (Last et al., 2017). Moreover, the presence of
vascular risk factors and chronic diseases, such as those that
were prevalent in our recruited sample, has been shown to
increase brain atrophy in elders (Debette et al., 2011; Habes
et al., 2016). Other transversal studies observed that physically
active elders can recruit additional brain resources to perform
cognitive and motor tasks (Hillman et al., 2002) and have higher
brain volume (Colcombe et al., 2003) than their sedentary
counterparts.
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Interestingly, Colcombe et al. (2003) showed that, when
healthy but physically inactive older adults were enrolled in a
6-month aerobic fitness program, both gray and white matter
volume increased compared to the control group having only
performed stretching and toning exercises. Likewise, a recent
randomized controlled trial (Best et al., 2015) with 155 older
women reported that those engaged in a 52-week resistance
training program vs. those that only performed toning and
balance interventions demonstrated better improvements in
muscle power and executive functions, and reduced cortical
atrophy at the 2 year follow-up; an effect that could be
attributed to the release of brain growth factors (Dishman
et al., 2006; Vaynman and Gomez-Pinilla, 2006). Based on
this evidence, we propose that the potentially lower rMTs
in “healthier” subgroups might reflect less brain atrophy
and/or richer inter-neuronal networks (higher M1 excitability)
within the precentral and motor cortex. Future studies should
investigate these observations in more detail, for instance by
directly measuring the skull-cortex distance at the hotspot using
anatomical magnetic resonance imaging (Stokes et al., 2013).
It could be hypothesized that if brain atrophy is the main
factor explaining our rMT results, then individuals with the
highest threshold should also demonstrate the highest skull-
cortex distance. The results obtained in the present study will
have to be reproduced in a larger cohort before any clear
conclusions can be drawn. If future work provides enough
evidence to support our findings, TMS outcome measures
such as the rMT could be used as a meaningful indicator
of changes in M1 function and excitability in the aging
population.
Results obtained with the contralateral silent period did
not confirm our initial hypothesis. Based on literature, it
was anticipated that longer cSP would be found in healthier
subgroups, because younger individuals or elders with better
motor skills demonstrated longer cSP as well (Fujiyama
et al., 2009, 2012). Conversely, we observed longer cSP
in participants taking medications at the first visit. TMS
measures of cortical inhibition such as the cSP are habitually
linked to motor planning, particularly when performing
more complex tasks (Reis et al., 2008; Levin et al., 2014).
However, there are discrepancies in the literature about how
these intracortical inhibitory/excitatory mechanisms are affected
by aging (cf. review by Levin et al., 2014). We propose
that part of this controversy might result from unexplored
factors, including those investigated in the present work.
For instance, five participants took antidepressive/anxiolytic
drugs, which can lengthen the cSP via serotonin-specific or
serotonin/norepinephrine reuptake inhibitors (Robol et al.,
2004), although this effect was not reported in other papers (cf.
review by Paulus et al., 2008). However, cSP length is directly
influenced by the intensity of the stimulation (Inghilleri et al.,
1993; Orth and Rothwell, 2004), and when the intensity is
expressed in % rMT as in the present work, longer cSP are
more likely to be observed in individuals with a higher rMT
(Kimiskidis et al., 2005). Therefore, the shorter cSP obtained
in our healthier subgroup might simply reflect the lowest rMT
levels. This explanation fits well with the lack of significant
difference of cSP length at the second visit, as the difference in
rMT levels was also lower then. The use of more comprehensive
cSP evaluations, such as finding the cSP threshold or constructing
RC curves for cSP lengths (Kimiskidis et al., 2005), should be
considered in the future.
Limitations
Results obtained in the present work might be affected by
a few limitations that are worth mentioning. First, a slight
but significant increase in rMT was detected between sessions
(2%), pointing out the possibility of a systematic error. The
participants’ experience of TMS after the first visit might
have influenced their attention or level of arousal during the
second session, which is recognized as potentially affecting
TMS outcomes (Chipchase et al., 2012). Increasing the number
of trials for rMT determination could have perhaps helped
attenuate these intersession differences. Since rMT determination
requires a lot of stimuli before testing the 50% rule of
the relative frequency method, we decided to test 4 out of
7 instead of 5 out of 10 to minimize fatigue and reduce
experimentation time (see also Groppa et al., 2012 for similar
approach). From a metrological perspective, the mean rMT
increase of 2% MSO observed in our study was within the
measurement error (i.e., 2.63% MSO), and was not systematically
observed across individuals, with five participants showing slight
decreases of rMT, and three subjects having unchanged rMT.
Altogether, these points highlight that our rMT estimation
criterion might have introduced a supplemental source of error,
and that further research is required to better characterize
the strengths and limits of existing rMT procedures (Awiszus,
2014).
It should also be pointed out that sample size was relatively
small, and that subgroups were not always balanced for
the analyses pertaining to the secondary objective. A small
sample size increases the confidence intervals associated with
reliability indicators and increases the risk of committing type
II errors (Portney and Watkins, 2009). The small number
of participants hence challenges the non-significant results
regarding our secondary objective, for example regarding the
impact of smoking on TMS-related measurements. Future studies
looking at the effect of smoking on TMS outcomes should also
focus on current smokers vs. individuals who never smoked, a
comparison that we were unable to make, as no current smoker
was recruited.
CONCLUSION
Our findings support the reliable use of rMT and cSP
with the aging population and provide reference levels
for the smallest detectable change and ICC values
that can be generalized to a future use for these TMS
measurements in this population. Ultimately, the use of
TMS measures could provide meaningful information
on age-related changes in the motor cortex and might
even be able to predict the development of sensorimotor
disorders or functional limitations in the future. This work
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also provides the first evidence that lifestyle habits and medical
conditions may have a significant impact on TMS outcomes in
community-dwelling elders. Researchers in the fields of TMS and
aging are thus encouraged to consider the potential influence of
these factors, especially when “healthy” elders are recruited to
provide comparative data for other populations with pathological
affections. In the meantime, our results underscore the impact
that poor lifestyle habits and chronic diseases might have on the
corticospinal system.
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